Editing B2M and CIITA to Create Hypoimmune Cell Lines for Cell Therapy
29 August 2023
Gene editing is a viable approach for reducing immunogenicity of iPSC-derived therapeutic cells. The B2M and CIITA HLA-regulatory genes are good targets.
How digital droplet PCR can improve CRISPR gene editing (with examples)
05 October 2021
Looking to understand how digital PCR can improve your genome editing projects? Learn how digital PCR can improve your CRISPR gene editing (with examples).
How CRISPR-SNIPER compares to other gene editing techniques
01 April 2020
Want to find out how CRISPR-SNIPER compares to other gene editing techniques? Discover the benefits of this advanced editing system on the REPROCELL blog.
![A Visual Guide to CRISPR-SNIPER Gene Editing [INFOGRAPHIC]](https://www.reprocell.com/hs-fs/hubfs/07AUG20%20crispr%20cas%20gene%20editing%20dna.jpeg?width=756&height=425&name=07AUG20%20crispr%20cas%20gene%20editing%20dna.jpeg)
A Visual Guide to CRISPR-SNIPER Gene Editing [INFOGRAPHIC]
30 March 2020
Discover the benefits of our advanced genome editing system in this visual guide to CRISPR-SNIPER gene editing [INFOGRAPHIC].
3 challenges facing the introduction of iPSC-derived therapies
12 February 2020
Discover three of the main challenges facing the introduction of iPSC-derived therapies on the REPROCELL blog.
Improve Gene-Editing Success with CRISPR-SNIPER Technology
29 October 2019
The Ultimate Guide to CRISPR-SNIPER technology: a gene-editing system that overcomes the limitations of conventional CRISPR systems.
What is CRISPR-SNIPER Gene Editing?
02 September 2019
Discover the definition of CRISPR-SNIPER and how this advanced gene editing system can improve your edits.